Kaku K - Search Results

1

Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise.

Kaku K, Kiyosue A, Inoue S, Ueda N, Tokudome T, Yang J, Langkilde AM. Kaku K, et al. Diabetes Obes Metab. 2014 Nov;16(11):1102-10. doi: 10.1111/dom.12325. Epub 2014 Jul 8. Diabetes Obes Metab. 2014. PMID: 24909293 Clinical Trial.

2

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial.

Kaku K, Inoue S, Matsuoka O, Kiyosue A, Azuma H, Hayashi N, Tokudome T, Langkilde AM, Parikh S. Kaku K, et al. Diabetes Obes Metab. 2013 May;15(5):432-40. doi: 10.1111/dom.12047. Epub 2013 Jan 25. Diabetes Obes Metab. 2013. PMID: 23194084 Clinical Trial.

3

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study.

Kaku K, Itayasu T, Hiroi S, Hirayama M, Seino Y. Kaku K, et al. Diabetes Obes Metab. 2011 Nov;13(11):1028-35. doi: 10.1111/j.1463-1326.2011.01460.x. Diabetes Obes Metab. 2011. PMID: 21682833 Clinical Trial.

4

Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial.

Kaku K, Enya K, Nakaya R, Ohira T, Matsuno R. Kaku K, et al. Diabetes Obes Metab. 2015 Jul;17(7):675-81. doi: 10.1111/dom.12467. Epub 2015 Apr 23. Diabetes Obes Metab. 2015. PMID: 25787200 Free PMC article. Clinical Trial.

5

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study.

Kaku K, Katou M, Igeta M, Ohira T, Sano H. Kaku K, et al. Diabetes Obes Metab. 2015 Dec;17(12):1198-201. doi: 10.1111/dom.12555. Epub 2015 Oct 23. Diabetes Obes Metab. 2015. PMID: 26277887 Clinical Trial.

6

Long-term safety and efficacy of fasiglifam (TAK-875), a G-protein-coupled receptor 40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes: a 52-week open-label phase III study.

Kaku K, Enya K, Nakaya R, Ohira T, Matsuno R. Kaku K, et al. Diabetes Obes Metab. 2016 Sep;18(9):925-9. doi: 10.1111/dom.12693. Epub 2016 Jun 29. Diabetes Obes Metab. 2016. PMID: 27178047 Clinical Trial.

7

Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes.

Kaku K, Rasmussen MF, Clauson P, Seino Y. Kaku K, et al. Diabetes Obes Metab. 2010 Apr;12(4):341-7. doi: 10.1111/j.1463-1326.2009.01194.x. Diabetes Obes Metab. 2010. PMID: 20380655 Clinical Trial.

8

Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study.

Seino Y, Miyata Y, Hiroi S, Hirayama M, Kaku K. Seino Y, et al. Among authors: kaku k. Diabetes Obes Metab. 2012 Oct;14(10):927-36. doi: 10.1111/j.1463-1326.2012.01620.x. Epub 2012 Jun 5. Diabetes Obes Metab. 2012. PMID: 22583697 Clinical Trial.

9

Low bilirubin levels are an independent risk factor for diabetic retinopathy and nephropathy in Japanese patients with type 2 diabetes.

Hamamoto S, Kaneto H, Kamei S, Shimoda M, Tawaramoto K, Kanda-Kimura Y, Kawasaki F, Hashiramoto M, Matsuki M, Mune T, Kaku K. Hamamoto S, et al. Among authors: kaku k. Diabetes Metab. 2015 Nov;41(5):429-31. doi: 10.1016/j.diabet.2015.05.003. Epub 2015 Jun 6. Diabetes Metab. 2015. PMID: 26054296 No abstract available.

10

Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance.

Kaku K, Kadowaki T, Terauchi Y, Okamoto T, Sato A, Okuyama K, Arjona Ferreira JC, Goldstein BJ. Kaku K, et al. Diabetes Obes Metab. 2015 Nov;17(11):1033-41. doi: 10.1111/dom.12507. Epub 2015 Jul 17. Diabetes Obes Metab. 2015. PMID: 26094974 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

687 results

Search Page

Filters